Idéal Investisseur
Français English
CAC 40 :
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35

Stock PHARMING GROUP (NL0010391025)

Sector : Pharmaceuticals & Biotechnology – Indices : AMX-INDEX, AEX ALL-SHARE

Price 1,42 €
Daily change -2,07 %
1 week -4,66 %
1 month 0,00 %
1 year +89,97 %

Last update : 24/04/2026 at 17:35:07 – Source: Euronext

Assurance vie

Market summary

As of 24/04/2026, stock PHARMING GROUP trades at 1,42 € , with a change of -2,07 % , and a market cap of 1 004 M€.

Open0,00 €
Previous close1,45 €
Volume7 740 983
Market cap1 004 M€
P/EN/A
Dividend / shareN/A
Float turnover0,00 %
MarketEuronext AMSTERDAM
Eligible PEA

Price and moving averages

Technical analysis PHARMING GROUP

50-day moving average1,45 €-2.00 % (below) Pivot1,43 €
Support level1,29 €-9.22 % Resistance level1,44 €+1.34 %
1-month volatility15,54 % Annualised volatility53,84 %
RSI (14d)48 Neutral Stochastic signal (14d)Achat
ATR (14d)0,05 Low volatility CMF (21d)-0,02 Weak selling pressure
Bollinger bands (20d) Neutral OBV (21d) Neutral (OBV stable)

Analyst consensus and recommendations

Insufficient data.

No analyst recommendation available.

Stock history and statistics

IPO dateMar 05, 2013
52-week high1,82 €52-week low1,27 €
All-time high50,02 €All-time low0,06 €
1-year volatility53,84 %Beta0,25

Financial calendar — PHARMING GROUP

📅
March 12, 2026 Annual results 2025
📅
April 2, 2026 Rapport annuel 2025
📅
May 7, 2026 Résultats Q1 2026
📅
May 28, 2026 Annual General Meeting
📅
July 30, 2026 Résultats Q2 2026
📅
November 5, 2026 Résultats Q3 2026

Recent news — PHARMING GROUP

Pharming Group announced on Friday, March 27, 2026, that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (E…

Pharming Group announces the approval by the Japanese Ministry of Health, Labour and Welfare of Joenja® (leniolisib), a selective inhibitor of phospho…

Pharming Group reports strong 2025 results with a 27% increase in revenue and a shift to operational profitability, marking a strategic turning point …

Pharming Group N.V. announces that it will present its unaudited preliminary financial results for the fourth quarter and the full year of 2025 on Thu…

Latest earnings

Annuels 2025
Revenue 376 M€
+26,6 %
EBITDA 43 M€
Net income 3 M€
+125,9 %
Free cash flow 64 M€
Net debt -63 M€

Analyses on PHARMING GROUP stock

No analysis has been published on this stock yet.

Frequently asked questions about PHARMING GROUP stock

What does the recent price action of PHARMING GROUP stock show?

PHARMING GROUP stock is currently trading around 1,42 €, down 2,07% and down 0,05% over one week.

Is PHARMING GROUP stock in a support or resistance zone?

Technical levels help place the stock. Support: 1,29 €. Resistance: 1,44 €.

How should the current volatility of PHARMING GROUP stock be interpreted?

Volatility is around 53,84%.

Ad
Chaque matin
Les signaux techniques du marché,
avant l'ouverture.
CAC 40 · SBF 120 · Signaux · Analystes
🤖
Édition du jour — avant bourse
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Signaux haussiers
+5,2%
+1,8%
+0,9%
📉 Signaux baissiers
-14%
-5,7%
🔄 Avis analystes
▲ 35 €
▼ 80 €
Inscrivez-vous pour tout voir →
Avant 9h chaque matin
Données Euronext
Analyse automatique IA
BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit